Journal profile · ENDOCRINOLOGY & METABOLISM
Endocrine
ISSN 1355-008X · eISSN 1559-0100 · Springer US · UNITED STATES · 12 issues per year · Founded 1995
Endocrine: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.24; hybrid open access; APC about USD 3,090; median 93 days to acceptance (118 articles, last 24 months); community-reported acceptance: about 75%; 344 articles in 2025; indexed in SCIE and Scopus.
The journal's website announces a move to full open access: We are pleased to announce that Endocrine will become a fully open access (OA) on 1 January 2027. Source ↗Publisher website ·
Scope
Aims, scope and focus
Endocrine is published by Springer US and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Thyroid Cancer Diagnosis and Treatment, Thyroid Disorders and Treatments and Growth Hormone and Insulin-like Growth Factors, together about 28.1% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism and Surgery. (generated from OpenAlex topic counts and CAS ranking data)
Announcement We are pleased to announce that Endocrine will become a fully open access (OA) on 1 January 2027. As a result, all submissions received from 8 September 2026 are subject to an article publication charge (APC) if accepted and published in the journal (unless a waiver is applied). Please see our FAQs which can be found at the bottom of this page for more information on APCs, funding options, waivers and the journal's transition to fully open access. Well-established as a major journal in today’s rapidly advancing experimental and clinical research areas, Endocrine publishes original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical research in all the different fields of endocrinology and metabolism. Articles will be accepted based on peer-reviews, priority, and editorial decision. Invited reviews, mini-reviews and viewpoints on relevant pathophysiological and clinical topics, as well as Editorials on articles appearing in the Journal, are published. Unsolicited Editorials will be evaluated by the editorial team. Outcomes of scientific meetings, as well as guidelines and position statements, may be submitted. The Journal also considers special feature articles in the field of endocrine genetics and epigenetics, as well as articles devoted to novel methods and techniques in endocrinology. Endocrine covers controversial, clinical endocrine issues. Meta-analyses on endocrine and metabolic topics are also accepted. Descriptions of single clinical cases and/or small patients studies are not published unless of exceptional interest. However, reports of novel imaging studies and endocrine side effects in single patients may be considered. Research letters and letters to the editor related or unrelated to recently published articles can be submitted. Endocrine covers leading topics in endocrinology such as neuroendocrinology, pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, Type 1 and Type 2 diabetes, hormones of male and female reproduction, adrenal diseases pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology. Endocrine’s editorial team is committed to provide rapid turn-around (first decision average just over three weeks) and publication within six months of acceptance.
From the journal's Aims & Scope
Research area (LetPub): ENDOCRINOLOGY & METABOLISM
Editor-in-chief Sebastiano FilettiPublisher website
Editorial board by country: 10 in mainland China (about 10%); most named Italy 27, Mainland China 10, India 7, United States 6, Greece 6 (98 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Thyroid Cancer Diagnosis and TreatmentMedicine11.3%
- Thyroid Disorders and TreatmentsMedicine8.6%
- Growth Hormone and Insulin-like Growth FactorsMedicine8.1%
- Pituitary Gland Disorders and TreatmentsMedicine8.1%
- Thyroid and Parathyroid SurgeryMedicine5.9%
- Adrenal and Paraganglionic TumorsMedicine4.5%
- Adrenal Hormones and DisordersMedicine4.1%
- Hormonal Regulation and HypertensionMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCAB AbstractsCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.24LetPub ·
- Impact factor (publisher) 2025
- 3.3Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.3Publisher website ·
- CiteScore 2026-06
- 5.4LetPub ·
- SJR 2026-06
- 0.98LetPub ·
- SNIP 2026-06
- 1.07LetPub ·
- h-index
- 74LetPub ·
- h-index
- 129OpenAlex ·
- i10-index
- 4,078OpenAlex ·
- 2-year mean citedness
- 3.64OpenAlex ·
- Self-citation rate
- 3%LetPub ·
- Share of gold OA articles
- 25.48%LetPub ·
Volume
- Articles per year
- 324LetPub ·
- Downloads per year (publisher) 2025
- 1,600,000Publisher website ·
Articles by year OpenAlex count · 7,135 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 301 | 98 | 66 |
| 2025 | 344 | 104 | 773 |
| 2024 | 497 | 146 | 3,313 |
| 2023 | 356 | 115 | 3,555 |
| 2022 | 333 | 128 | 4,580 |
| 2021 | 392 | 170 | 6,753 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
93 daysMedian, submission to acceptance · P25–P75 70 days – 129 days
- Acceptance to online
- median 22 days (119 articles)
- Submission to online
- median 116 days
- Sample
- 118 articles with submission and acceptance dates (887 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1.5 monthsLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
- Submission to first decision
- 21 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,090 / EUR 4,990 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare9 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 6,000 words
- Reference style
- Numbered, in order of citation
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Highlights
- Optional
- Graphical abstract
- Optional
- Cover letter
- Required
Article types accepted10, with length limits
- book review9. Book review This contribution should be a short evaluation from an expert in the field on a relevant book in a certain area of endocrinology. This article sh…Length not stated
- brief report, or that present a conceptual advance. Brief reports should be presented in a very concise way (limit of 1600 words (excluding abstract, references, and table/…main text ≤ 1,600 words
- comment6. Comment This contribution should be solicited by the Editors and deal with a controversial topic in either basic or clinical endocrinology on which the autho…Length not stated
- correspondence10. Correspondence Text is limited to 750 words, with no abstract. There may be 1 figure, up to 3 references, and no more than 3 authors, with author affiliatio…Length not stated
- editorialManuscript categories 1. Editorial This contribution should be solicited by the Editors and relates to the topic of one or more contributions published in the s…main text ≤ 4,000 words
- meta-analysisManuscript categories 1. Editorial This contribution should be solicited by the Editors and relates to the topic of one or more contributions published in the s…Length not stated
- mini-review3. Mini-Review This contribution is also usually solicited by the Editors. If unsolicited, the authors are advised to contact the Editor-in-Chief (editor.endocr…Length not stated
- research8. Research This contribution should contain original controlled experimental data of basic and clinical research. The manuscript should be organized in the fol…Length not stated
- reviewManuscript categories 1. Editorial This contribution should be solicited by the Editors and relates to the topic of one or more contributions published in the s…Length not stated
- systematic reviewManuscript categories 1. Editorial This contribution should be solicited by the Editors and relates to the topic of one or more contributions published in the s…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Endocrine, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
4-6 keywords required Model summary
Please provide 4 to 6 keywords which can be used for indexing purposes.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- 12 issues per year
- Founded
- 1995
- ISSN
- 1355-008X
- Electronic ISSN
- 1559-0100
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Endocrine
What CAS zone is Endocrine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Endocrine is in Zone 3 of Medicine, and in Zone 3 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Endocrine?
The latest impact factor listed by LetPub is 3.24; CiteScore 5.4, h-index 129.
How long does peer review take at Endocrine?
Based on the dates recorded on 118 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 93 days (interquartile range 70–129 days); authors report an average review time of about 1.5 months; the community-reported acceptance is “about 75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Endocrine?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 6,000 words; Reference style: Numbered, in order of citation; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Highlights: Optional; Graphical abstract: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Endocrine based?
Of the 98 board members whose country the journal's board page names, 10 (about 10%) are in mainland China; the countries named most often are Italy (27), Mainland China (10) and India (7). Counted from the institutions listed on the board page; for reference only.
Which databases index Endocrine?
According to LetPub and DOAJ records, Endocrine is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Endocrine open access, and what is the APC?
Endocrine is a hybrid journal. For open-access publication: APC about USD 3,090.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .